Item 1.02 Termination of a Material Definitive Agreement.

On July 30, 2012, MusclePharm Corporation (the "Company") provided a notice of termination to TCA Global Credit Master Fund, LP, a limited partnership organized and existing under the laws of the Cayman Islands ("TCA"), pursuant to which the Company advised TCA of the termination of the Committed Equity Facility Agreement, dated as of July 13, 2012 (the "Equity Facility"), among the Company and TCA, which such termination should proceed pursuant to the terms and conditions therein contained. In conjunction with the termination of the Equity Facility, the Company will terminate the Registration Rights Agreement, by and among the Company and TCA, dated as of July 13, 2012 (the "Registration Rights Agreement"). Upon termination of the Registration Rights Agreement the Company will no longer be under any obligation to register any of its securities for TCA.

The above description of the Equity Facility and Registration Rights Agreement do not purport to be complete and are qualified in their entity by reference to exhibits 10.1 and 10.2 respectively, of the Company's Current Report on Form 8-k filed with the Commission on July 20, 2012.

Item 9.01 Financial Statements and Exhibits

Exhibit No. Description 10.1 Form of Committed Equity Facility Agreement, dated July 13, 2012, by and between MusclePharm Corporation and TCA Global Credit Master Fund LP (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-k filed with the Commission on July 20, 2012) 10.2 Form of Registration Rights Agreement, dated July 13, 2012, by and between MusclePharm Corporation and TCA Global Credit Master Fund LP (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-k filed with the Commission on July 20, 2012)